Antagonistische Antikörper gegen EPHB3

Patent europeic · EP2494988 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2494988
Numer da la dumonda
EP12167762
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
06-12-2007
Publitgà
05-09-2012
Concedì
30-09-2015
Stritgà
31-12-2015
Motiv
Taxa annuala betg pajada
Classas IPC
A61K 39/395 (2006.01)
A61P 25/00 (2006.01)
A61P 9/00 (2006.01)
A61P 1/00 (2006.01)
Prioritad
US 873386 P 07.12.2006
Derivà da
EP07865309
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 20-07-2016

    Stritgà, taxa betg pajada

    Published in Swissreg on 20.07.2016

  2. 30-09-2015

    Concedì

    Published in Swissreg on 30.09.2015

Partidas

Possessur

Novartis AG

Lichtstrasse 35, 4056 Basel

Xoma Technology Ltd.

XOMA Technology Ltd.

Clarendon House 2 Church Street, Hamilton HM11, BM

Inventur

Masat, Linda

Walnut Creek, CA 94598, US

Hsu, Ssucheng Jeff

Pinole, CA 94564, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.